ESC 2026: Abbott presents positive longer-term dual ablation catheter data
New data from Abbott has demonstrated longer-term safety and effectiveness of its TactiFlex Duo ablation catheter in treating atrial fibrillation…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Sustaining long-term follow-up in cell and gene therapies
Diego Correa, VP and global head, CAGT Center of Excellence, IQVIA, and Jip Klerks, product strategy lead, real-world solutions at…
-
Clinical trial success increasingly dependent on strategic collaborations and tech applications
As clinical trials become more expensive to run, well-rationalised collaboration and budgetary planning dictates are crucial, while unlocking valuable data…
-
How RWD is shaping the next era of healthcare decision-making
Sujay Jadhav, CEO of Verana Health, outlines the best practices to ensure real-world data has a beneficial impact in clinical…
-
AI in clinical trial finance
Sitaram Srivatsavai, senior director and head of engineering for product suites, IQVIA, explores how the right AI strategy can unlock…
-
Why psychiatry needs better patient outcome data on medical cannabis
Dr Imogen Kretzschmar, consultant psychiatrist at Mamedica, examines medical cannabis's mental health benefits for patients under specialist supervision. Dr Imogen…
-
Hyperfine’s portable MRI system demonstrates time-saving benefit in new data readout
Hyperfine has shared new data demonstrating time-saving advantages for its portable brain MRI system’s integration into emergency department workflows versus…
-
Site success in clinical trials begins with financial certainty
Carolina Carrasco, senior director at IQVIA, explores how fragmented financial workflows can create administrative burden and uncertainty for trial sites.…
-
Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial
Jupiter Endovascular has shared positive pivotal trial results for its Vertex pulmonary embolectomy system in treating pulmonary embolism (PE). The…
-
What happens when protocol data finally flows
Rob DiCicco, vice president of portfolio management, and Bill Illis, workstream leader, digital data flow at TransCelerate BioPharma, highlight the advantages of…